Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

2.

Clinician-trialist rounds: 4. why not do an N-of-1 RCT?

Sackett DL.

Clin Trials. 2011 Jun;8(3):350-2. doi: 10.1177/1740774511404718. No abstract available.

PMID:
21730083
4.

Why randomized controlled trials fail but needn't: a new series is launched.

Sackett DL, Hoey J.

CMAJ. 2000 May 2;162(9):1301-2. No abstract available.

5.

The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.

Lader EW, Cannon CP, Ohman EM, Newby LK, Sulmasy DP, Barst RJ, Fair JM, Flather M, Freedman JE, Frye RL, Hand MM, Jesse RL, Van de Werf F, Costa F; American Heart Association.

Circulation. 2004 Jun 1;109(21):e302-4. Review. No abstract available.

6.

The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.

Lader EW, Cannon CP, Ohman EM, Newby LK, Sulmasy DP, Barst RJ, Fair JM, Flather M, Freedman JE, Frye RL, Hand MM, Jesse RL, Van de Werf F, Costa F; American Heart Association.

Circulation. 2004 Jun 1;109(21):e305-7. Review. No abstract available.

7.

Randomisation in clinical trials.

Beller EM, Gebski V, Keech AC.

Med J Aust. 2002 Nov 18;177(10):565-7. No abstract available.

PMID:
12429008
8.

Why Sackett's analysis of randomized controlled trials fails, but needn't.

Shapiro SH, Glass KC.

CMAJ. 2000 Oct 3;163(7):834-5. No abstract available.

9.

Efficient management of randomised controlled trials: nature or nurture.

Farrell B.

BMJ. 1998 Oct 31;317(7167):1236-9. Review. No abstract available.

10.

Commentary: Measuring the success of blinding in RCTs: don't, must, can't or needn't?

Sackett DL.

Int J Epidemiol. 2007 Jun;36(3):664-5. No abstract available.

PMID:
17675306
11.

Design of randomized controlled trials.

Stanley K.

Circulation. 2007 Mar 6;115(9):1164-9. Review. No abstract available.

12.

Planning of clinical trials.

Boissel JP.

J Intern Med. 2004 Apr;255(4):427-38.

13.

Limits of the applicability and generalizability of drug trials in mania.

Licht RW.

Bipolar Disord. 2002;4 Suppl 1:66-8.

PMID:
12479682
14.

Sample size in guidelines trials.

Bland JM.

Fam Pract. 2000 Feb;17 Suppl 1:S17-20.

PMID:
10735263
15.

What is right and what is wrong about evidence-based medicine?

Julian DG.

J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S2-5.

PMID:
12950509
16.

Producing better evidence on how to improve randomised controlled trials.

Adamson J, Hewitt CE, Torgerson DJ.

BMJ. 2015 Sep 25;351:h4923. doi: 10.1136/bmj.h4923. No abstract available.

PMID:
26408289
17.

Clinical trials: a summary.

Wilhelmsen L, Held P, Wedel H.

J Intern Med. 2004 Oct;256(4):284-7. Review. No abstract available.

18.

How to evaluate manual therapy: value and pitfalls of randomized clinical trials.

Koes BW.

Man Ther. 2004 Nov;9(4):183-4. No abstract available.

PMID:
15522642
19.

Statistical considerations in evaluating pharmacogenomics-based clinical effect for confirmatory trials.

Wang SJ, O'Neill RT, Hung HJ.

Clin Trials. 2010 Oct;7(5):525-36. doi: 10.1177/1740774510375455. Epub 2010 Jul 1.

PMID:
20595242
20.

Neonatal trials need thousands, not hundreds, to change global practice.

Tarnow-Mordi W, Kumar P, Kler N.

Acta Paediatr. 2011 Mar;100(3):330-3. doi: 10.1111/j.1651-2227.2011.02141.x. No abstract available.

PMID:
21281339

Supplemental Content

Support Center